Literatur
-
1
duBois R M.
Corticosteriods in sarcoidosis: friend or foe.
Eur Respir J.
1994;
7
1203-1209
-
2
Sharma O.
Pulmonary sarcoidosis and corticosteroids.
Am Rev Respir Dis.
1993;
147
1598-1600
-
3 Endres P, Müller-Quernheim J. Alveolitiden und granulomatöse Lungenerkrankungen. In: Ferlinz R, ed. Pneumologie in Klinik und Praxis Stuttgart: Thieme 1994: 487-540
-
4
Schaberg T, Schonfeld N, Loddenkemper R, Lode H.
Therapie der Sarkoidose.
Dtsch Med Wochenschr.
1995;
120 (20)
725-727
-
5
Müller-Quernheim J, Dalhoff K, Schnabel A.
Immunsuppressive Therapie bei interstitiellen Lungenerkrankungen und immunologisch vermittelten Pneumonitiden.
Internist (Berl).
1997;
38 (6)
553-561
-
6
Deutsche Gesellschaft für Pneumologie .
Empfehlungen zur Diagnostik und Therapie der Sarkoidose.
Pneumologie.
1998;
52 (1)
26-30
-
7
Lynch J PR.
Pulmonary sarcoidosis: current concepts & controversies.
Compr Ther.
1997;
23 (3)
197-210
-
8
Judson M A.
An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment.
Chest.
1999;
115 (4)
1158-1165
-
9
DeRemee R.
The present status of treatment of pulmonary sarcoidosis: A house divided.
Chest.
1977;
71
388-393
-
10
Hillerdal G, Nöu E, Osterman K, Schmekel B.
Sarcoidosis: epidemiology and prognosis. A 15-year European study.
Am Rev Respir Dis.
1984;
130
29-32
-
11
Vestbo J, Viskum K.
Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis.
Sarcoidosis.
1994;
11
123-125
-
12
Müller-Quernheim J.
Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology.
Sarcoidosis Vasc Diffuse Lung Dis.
1998;
15 (1)
22-37
-
13
Israel H, Fouts D, Beggs R.
A controlled trial of prednisone treatment of sarcoidosis.
Am Rev Respir Dis.
1973;
107
609-614
-
14
Zaki M H, Lyons H A, Leilop L, Huang C T.
Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study.
N Y State J Med.
1987;
87
496-499
-
15
Gottlieb J E, Israel H L, Steiner R M, Triolo J, Patrick H.
Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy.
Chest.
1997;
111
623-631
-
16
Müller-Quernheim J.
Sarcoidosis: immunopathogenetic concepts and their clinical application.
Eur Respir J.
1998;
12 (3)
716-738
-
17
Pinkston P, Saltini C, Müller-Quernheim J, Crystal R G.
Corticosteroid therapy suppresses spontaneous interleukin-2 release and spontaneous proliferation of lung T-lymphocytes of patients with active pulmonary sarcoidosis.
J Immunol.
1987;
139
755-760
-
18
Baughman R P, Strohofer S A, Buchsbaum J, Lower E E.
Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.
J Lab Clin Med.
1990;
115
36-42
-
19
Strausz J, Männel D, Pfeifer S, Borkowski A, Ferlinz R, Müller-Quernheim J.
Spontaneous monokine release by alveolar macrophages in chronic sarcoidosis.
Int Archs Allergy appl Immun.
1991;
96
68-75
-
20
Baumann M H, Strange C, Sahn S A.
Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal.
AJR Am J Roentgenol.
1990;
154 (3)
481-485
-
21
Hunninghake G W, Gilbert S, Pueringer R et al.
Outcome of the treatment of sarcoidosis.
Am J Respir Crit Care Med.
1994;
149
893-898
-
22
Gibson G, Prescott R, Muers M et al.
British Thoracic Society sarcoidosis study: Effects of long term corticosteroid treatment.
Thorax.
1996;
51
238-247
-
23
Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J.
Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis.
Am J Respir Crit Care Med.
1996;
154
713-719
-
24
Lynch III J P, McCune W J.
Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders.
Am J Respir Crit Care Med.
1997;
155
395-420
-
25
Pacheco Y, Marechal C, Marechal F, Biot N, Perrin-Fayolle M.
Azathioprine treatment of chronic pulmonary sarcoidosis.
Sarcoidosis.
1985;
2
107-113
-
26
Hammond J, Bateman E.
Successful treatment of life-threatening steroid-resistant pulmonary sarcoidosis with cyclosporin in a patient with systemic lupus erythematosus.
Respir Med.
1990;
84
77-80
-
27
Martinet Y, Pinkston P, Saltini C, Spurzem J, Müller-Quernheim J, Crystal R G.
Evaluation of the in vitro and in vivo effects of cyclosporine on the T-lymphocyte alveolitis of active pulmonary sarcoidosis.
Am Rev Respir Dis.
1988;
138
1242-1248
-
28
Lower E E, Broderick J P, Brott T G, Baughman R P.
Diagnosis and management of neurological sarcoidosis.
Arch Intern Med.
1997;
157 (16)
1864-1868
-
29
Lower E E, Baughman R P.
The use of low dose methotrexate in refractory sarcoidosis.
Am J Med Sci.
1990;
299 (3)
153-157
-
30
Müller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U.
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen.
Eur Respir J.
1999;
14 (5)
1117-1122
-
31
Zabel P, Entzian P, Dalhoff K, Schlaak M.
Pentoxifylline in treatment of sarcoidosis.
Am J Respir Crit Care Med.
1997;
155
1665-1669
-
32
Baughman R P, Lower E E.
Steroid-sparing alternative treatments for sarcoidosis.
Clin Chest Med.
1997;
18 (4)
853-864
-
33
Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S.
Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.
J Am Acad Dermatol.
1995;
32 (5 Pt 2)
866-869
Prof. Dr J Müller-Quernheim
Medizinische Klinik Forschungszentrum Borstel
Parkallee 35 23845 Borstel
Email: E-mail: jmq@fz-borstel.de
